Drug Profile
Research programme: anti-hepatitis C virus monoclonal antibodies - GENimmune
Alternative Names: ED 004; GNI 104; HCV hu mAbs - GENimmuneLatest Information Update: 09 May 2008
Price :
$50
*
At a glance
- Originator GENimmune
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators; Virus internalisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 12 Feb 2008 Discontinued - Preclinical for Hepatitis C in Belgium (Parenteral)
- 11 Dec 2007 A lead monoclonal antibody receives orphan drug status from the European Commission for the prevention of hepatitis C virus re-infection after liver transplantation
- 28 Nov 2007 This programme is available for licensing (http://www.innogenetics.com)